Stock Companion LogoStock Companion
Log inGet Started
Backtest
Log inGet Started Free
Stock DetailsAZN

AstraZeneca PLC (AZN) — AI Signal & News Sentiment

Price
$172.06
Today
+0.33%
Signal
BUY
News sentiment, 0–100 (10 articles)
71 · Bullish
050 Neutral100

AstraZeneca PLC (AZN) closed at $172.06, up 0.33% in its last regular session. News sentiment is bullish, at 71 on a scale from 0 to 100 where 50 is neutral, based on 10 articles analysed in the last 72 hours. Stock Companion's multi-factor model currently rates AZN a BUY with a high risk profile.

Data as of Mon, 26 Oct 2026 22:33:55 GMT. Signals are generated by an automated model and are not financial advice. How our signals work.

About AstraZeneca PLC (AZN)

AstraZeneca PLC (AZN) is a pharmaceuticals company listed in the United Kingdom, carries a market value of about $201.3 billion, has been publicly listed since 2007. Stock Companion tracks it alongside 18 other healthcare names and scores every headline about it with state-of-the-art AI models trained specifically on financial data. Not investment advice.

Key statistics

Key statistics for AstraZeneca PLC (AZN)
Open$171.54
Day's range$170.68 — $172.37
Previous close$171.49
Market value$201.3 billion
IndustryPharmaceuticals
Listed inthe United Kingdom
ExchangeLONDON STOCK EXCHANGE
Trading currencyUSD
Public since2007

Latest scored headlines for AZN

The 5 most recent of the 10 headlines scored in the last 72 hours, each with its own reading, from state-of-the-art AI models trained specifically on financial data, on the same 0 to 100 scale, where 50 is neutral. The average across all 10 headlines is the sentiment figure above.

  1. 17Is AstraZeneca’s Pipeline Fuel Enough to Spark a Post-Earnings Breakout on Oct. 30? — Yahoo, 2026-10-26
  2. 95Pathos AI completes $237m Series E round to expand oncology pipeline — Yahoo, 2026-10-26
  3. 97Amgen, AstraZeneca Drug Combo Shows Promising Survival Results in Tough-To-Treat Lung Cancer — Benzinga, 2026-10-26
  4. 24AstraZeneca: Stomach Cancer Drug With $3 to $5 Billion Sales Potential, and One Significant Wrinkle — Yahoo, 2026-10-26
  5. 91Astrazeneca Reports Higher Patient Survival Rates in Stomach, Lung-Cancer Drug Trials — Yahoo, 2026-10-26

What is Stock Companion's signal for AZN?

Stock Companion's multi-factor model currently rates AZN a BUY with a high risk profile. That rating combines news sentiment of 71 out of 100 across 10 headlines scored in the last 72 hours with the ticker's price and volatility factors. It is a model output rather than a recommendation, and it moves as the news does. Not investment advice.

What is AZN's news sentiment today?

71 on a scale from 0 to 100, which we label bullish. It is the average reading that state-of-the-art AI models trained specifically on financial data give the 10 headlines published about AstraZeneca PLC (AZN) in the last 72 hours, recomputed as new headlines arrive. 50 is neutral. We call 48 to 52 neutral; 53 to 59 slightly bullish, 60 to 74 bullish and 75 or more very bullish; 41 to 47 slightly bearish, 26 to 40 bearish and 25 or less very bearish. Not investment advice.

How does Stock Companion score AZN's news?

Every headline is scored by state-of-the-art AI models trained specifically on financial data, and those scores are averaged into the one number shown above, on a scale from 0 to 100 where 50 is neutral. That number is the same for every visitor, on every page, whatever their plan. The signal then adds price and volatility factors to it. The full method is on our methodology page. Not investment advice.

Sources and method: every headline above is scored by state-of-the-art AI models trained specifically on financial data and the aggregate is the same for every visitor. How our signals work.

Put AZN sentiment on your own site

This badge shows the same news sentiment score this page shows, from 0 to 100 over the last 72 hours of headlines. It updates itself, and is free to use on any site, with no account and no attribution fee. We ask only that you keep the link.

AstraZeneca PLC news sentiment badge
<a href="https://stockcompanion.com/stock/azn" target="_blank" rel="noopener">
  <img src="https://stockcompanion.com/embed/sentiment/azn" alt="AstraZeneca PLC news sentiment by Stock Companion" width="240" height="60" loading="lazy">
</a>

The whole table of tickers is at /data/sentiment, and how the number is produced is at /methodology. Sentiment is an automated reading of news headlines, not financial advice.

More Healthcare & Biotechnology coverage

Other healthcare names we score: Healthcare & Biotechnology sectorAbbott (ABT)Amgen (AMGN)Intuitive Surgical (ISRG)Pfizer (PFE)Stryker (SYK)Vertex Pharmaceuticals (VRTX)